Articles citing this paper
Bioisosteric Fluorine in the Clandestine Design of Synthetic Cannabinoids
Shane M. Wilkinson A , Samuel D. Banister A B C and Michael Kassiou A B D E
+ Author Affiliations
- Author Affiliations
A School of Chemistry, Sydney University, Sydney, NSW 2006, Australia.
B Brain and Mind Research Institute, 100 Mallett St, Camperdown, NSW 2050, Australia.
C Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
D Faculty of Health Science, Sydney University, Sydney, NSW 2006, Australia.
E Corresponding author. Email: michael.kassiou@sydney.edu.au
Australian Journal of Chemistry 68(1) 4-8 https://doi.org/10.1071/CH14198
Submitted: 1 April 2014 Accepted: 15 April 2014 Published: 22 May 2014
27 articles found in Crossref database.
The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities
Longworth Mitchell,
Banister Samuel D.,
Mack James B. C.,
Glass Michelle,
Connor Mark, Kassiou Michael
Forensic Toxicology. 2016 34(2). p.286
19F and 1H quantitative-NMR spectroscopic analysis of fluorinated third-generation synthetic cannabinoids
Naqi Husain A.,
Woodman Timothy J.,
Husbands Stephen M., Blagbrough Ian S.
Analytical Methods. 2019 11(24). p.3090
Fatal intoxication by 5F–ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q‐TOFMS
Kusano Maiko,
Zaitsu Kei,
Taki Kentaro,
Hisatsune Kazuaki,
Nakajima Jun'ichi,
Moriyasu Takako,
Asano Tomomi,
Hayashi Yumi,
Tsuchihashi Hitoshi, Ishii Akira
Drug Testing and Analysis. 2018 10(2). p.284
New Psychoactive Substances (2018)
Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice
Humburg Bree A.,
Jordan Chloe J.,
Zhang Hai‐Ying,
Shen Hui,
Han Xiao,
Bi Guo‐Hua,
Hempel Briana,
Galaj Ewa,
Baumann Michael H., Xi Zheng‐Xiong
Addiction Biology. 2021 26(4).
Enzymatic Defluorination of a Terminally Monofluorinated Pentyl Moiety: Oxidative or Hydrolytic Mechanism?
Haschimi Belal,
Willecke Florian,
Mundinger Stephan,
Hüttel Wolfgang,
Jessen Henning,
Müller Michael, Auwärter Volker
Drug Metabolism and Disposition. 2024 52(5). p.337
The Chemistry of Cannabis and Cannabinoids
Duggan Peter J.
Australian Journal of Chemistry. 2021 74(6). p.369
Neurobiology and Physiology of the Endocannabinoid System (2023)
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
Banister Samuel D.,
Moir Michael,
Stuart Jordyn,
Kevin Richard C.,
Wood Katie E.,
Longworth Mitchell,
Wilkinson Shane M.,
Beinat Corinne,
Buchanan Alexandra S.,
Glass Michelle,
Connor Mark,
McGregor Iain S., Kassiou Michael
ACS Chemical Neuroscience. 2015 6(9). p.1546
Metabolism of the new synthetic cannabinoid EG-018 in human hepatocytes by high-resolution mass spectrometry
Diao Xingxing,
Carlier Jeremy,
Zhu Mingshe, Huestis Marilyn A.
Forensic Toxicology. 2018 36(2). p.304
Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Banister Samuel D.,
Stuart Jordyn,
Kevin Richard C.,
Edington Amelia,
Longworth Mitchell,
Wilkinson Shane M.,
Beinat Corinne,
Buchanan Alexandra S.,
Hibbs David E.,
Glass Michelle,
Connor Mark,
McGregor Iain S., Kassiou Michael
ACS Chemical Neuroscience. 2015 6(8). p.1445
Discrimination between closely related synthetic cannabinoids by GC–Cold–EI–MS
Smolianitski‐Fabian Evgeny,
Cohen Etia,
Dronova Marina,
Voloshenko‐Rossin Anna, Lev Ovadia
Drug Testing and Analysis. 2018 10(3). p.474
The Complex Connection Between Cannabis and Schizophrenia (2018)
The chemistry and pharmacology of synthetic cannabinoid SDB‐006 and its regioisomeric fluorinated and methoxylated analogs
Banister Samuel D.,
Olson Alexander,
Winchester Matthew,
Stuart Jordyn,
Edington Amelia R.,
Kevin Richard C.,
Longworth Mitchell,
Herrera Marco,
Connor Mark,
McGregor Iain S.,
Gerona Roy R., Kassiou Michael
Drug Testing and Analysis. 2018 10(7). p.1099
Psychosis and synthetic cannabinoids
Deng Huiqiong,
Verrico Christopher D.,
Kosten Thomas R., Nielsen David A.
Psychiatry Research. 2018 268 p.400
The identification of synthetic cannabinoids surface coated on herbal substrates using solid-state nuclear magnetic resonance spectroscopy
Burns N.K.,
Theakstone A.G.,
Zhu H.,
O’Dell L.A.,
Pearson J.R.,
Ashton T.D.,
Pfeffer F.M., Conlan X.A.
Analytica Chimica Acta. 2020 1104 p.105
Neuropharmacology of New Psychoactive Substances (NPS) (2016)
Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues
Banister Samuel D.,
Stuart Jordyn,
Conroy Trent,
Longworth Mitchell,
Manohar Madhura,
Beinat Corinne,
Wilkinson Shane M.,
Kevin Richard C.,
Hibbs David E.,
Glass Michelle,
Connor Mark,
McGregor Iain S., Kassiou Michael
Forensic Toxicology. 2015 33(2). p.355
Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others
Tokunaga Etsuko,
Akiyama Hidehiko,
Soloshonok Vadim A.,
Inoue Yuki,
Hara Hideaki,
Shibata Norio, Pizzo Salvatore V
PLOS ONE. 2017 12(8). p.e0182152
Fluorine Chemistry
Hunter Luke
Australian Journal of Chemistry. 2015 68(1). p.3
Post-aggression suicide under the influence of new psychoactive substances AMB–FUBINACA and U-47700
Romańczuk Agnieszka,
Rojek Sebastian,
Kula Karol,
Maciów-Głąb Martyna,
Synowiec Kamil,
Moskała Artur,
Rzepecka-Woźniak Ewa, Kłys Małgorzata
Legal Medicine. 2022 56 p.102053
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1H‐indole‐3‐carboxamide (STS‐135)
Jones Sabrina,
Yarbrough Azure L.,
Fantegrossi William E.,
Prather Paul L.,
Bush John M.,
Radominska‐Pandya Anna, Fujiwara Ryoichi
Pharmacology Research & Perspectives. 2020 8(1).
In vitro metabolism of new synthetic cannabinoid SDB-006 in human hepatocytes by high-resolution mass spectrometry
Diao Xingxing,
Carlier Jeremy,
Scheidweiler Karl B., Huestis Marilyn A.
Forensic Toxicology. 2017 35(2). p.252
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
Banister Samuel D.,
Longworth Mitchell,
Kevin Richard,
Sachdev Shivani,
Santiago Marina,
Stuart Jordyn,
Mack James B. C.,
Glass Michelle,
McGregor Iain S.,
Connor Mark, Kassiou Michael
ACS Chemical Neuroscience. 2016 7(9). p.1241
Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes
Diao Xingxing,
Scheidweiler Karl B.,
Wohlfarth Ariane,
Zhu Mingshe,
Pang Shaokun, Huestis Marilyn A.
Forensic Toxicology. 2016 34(2). p.256
New psychoactive substances: psychiatrist's view
Antsyborov Andrey Viktorovich, Dubatova Irina Vladimirovna
Interactive science. 2019 (6 (40)). p.57
Extraction, identification and detection of synthetic cannabinoids found pre-ban in herbal products in Victoria, Australia
Burns Niki K.,
Ashton Trent D.,
Stevenson Paul G.,
Pearson James R.,
Fox I. Leona,
Pfeffer Frederick M.,
Francis Paul S.,
Smith Zoe M.,
Barnett Neil W.,
Chen Lifen,
White Jonathan M., Conlan Xavier A.
Forensic Chemistry. 2018 7 p.19
